CA 15-3: A multicentre evaluation of automated and manual tests

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 1, 1996, Pages 77-84

  Huber, Peter R ^a,e   Bischof, Paul ^a   Kretschmer, Robert ^b   Truschnig, Martie ^b   Haiwachs, Gabriele ^c   Schmidt, Marianne ^d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN;

ARTICLE; AUTOANALYSIS; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST TUMOR; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; MULTICENTER STUDY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

EID: 0030065724     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hilkens J, Buijs F, Hilgers J, Hageman Ph, Calafat J, Sonnenberg A, van der Valk M. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34:197-206.
2. Hayes DF, Zurawski V, Kufe D. Comparison of circulating CA 15-3 and carcinoembryogenic antigen levels in patients with breast cancer. J Clin One 1986; 4:1542-50.
3. Tobias R, Rothwell C, Wagner J, Green A, Lin Y-SV. Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumour associated antigen 115D8/DF3. Clin Chem 1985; 31:986.
4. Colomer R, Ruibal A, Genolla J, Rubio D, Del Campo JM, Bodi R, Salvador L. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases. Breast Cancer Res Treat 1985; 13:123 -33.
5. Safi F, Kohler I, Röttinger E, Beger HG. The value of the tumour marker CA 15-3 in diagnosing and monitoring breast cancer. Cancer 1991; 68:574-82.
6. Colomer R, Ruibal A, Genolla J, Salvator L. Circulating CA 15-3 antigen levels in nonmammary malignancies. Br J Cancer 1989; 64:1674-81.
7. Fiore MD, Mitchell JE, Doan T, Nelson R, Winter G, Grandone C, et al. The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem 1988; 34 (9):1726-32.
8. Ruibal A, Genolla J, Rosell M, Moragas M. El CA 15-3 ELSA serio en patalogias no tumorales [letter]. Med Clin (Bare) 1987; 88:476.
9. Package insert: BMC ES 300 and Enzymun CA 15-3 Test.
10. Package insert: Sorin ETI-CA-15-3-Test.
11. CLIA 88: Clinical Laboratory Improvement Amendments of 1988, final rule, Federal Register / Vol. 57, No. 40, 70017288 / Part II (1992), United States Government Printing Office.
12. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods: application of linear regression procedure for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 1983; 21:709-20.